Efficacy of Platelet-rich Plasma in Improving Postoperative Scarring After Cesarean Delivery

Inclusion Criteria: * Female patients, 18 to 45 years old. Scheduled for elective or emergency cesarean section at the participating center. * Singleton pregnancy (one fetus). Ability to provide written informed consent. Agreement to comply with the study protocol and follow-up visits at day 7 and day 40 postpartum. Exclusion Criteria: * Known coagulation disorders (e.g., thrombocytopenia, hemophilia). Platelet count below 150,000/μL at the time of enrollment. Use of anticoagulant or antiplatelet therapy within 7 days before surgery. Active infection at the surgical site. History of autoimmune diseases affecting wound healing (e.g., lupus, scleroderma). * Known keloid formation tendency (optional: include if you want to exclude high-risk scarring profiles). * Multiple pregnancies (twins, triplets, etc.). Patients participating in another interventional clinical trial could interfere with outcomes. * Inability to follow up for the postoperative evaluations at 7 and 40 days. Refusal to consent or withdrawal of consent at any point